We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

244 hedge funds and large institutions have $1.86B invested in Supernus Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 91 increasing their positions, 76 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 19

30% more capital invested

Capital invested by funds: $1.42B → $1.86B (+$433M)

20% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 76

8% more funds holding

Funds holding: 225 → 244 (+19)

1.55% more ownership

Funds ownership: 102.49% → 104.05% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

23% less call options, than puts

Call options by funds: $2.16M | Put options by funds: $2.79M

Holders
244
Holders Change
+19
Holders Change %
+8.44%
% of All Funds
4.2%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
39
Increased
91
Reduced
76
Closed
19
Calls
$2.16M
Puts
$2.79M
Net Calls
-$636K
Net Calls Change
+$182K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.7M
2
IBT
International Biotechnology Trust
United Kingdom
+$9.4M
3
EA
Emerald Advisers
Pennsylvania
+$7.93M
4
WP
Woodline Partners
California
+$7.33M
5
Citadel Advisors
Citadel Advisors
Florida
+$7.05M

Top Sellers

Rank Fund Capital Flow
1
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Illinois
-$11.5M
2
SCM
Soleus Capital Management
Connecticut
-$7.46M
3
Millennium Management
Millennium Management
New York
-$7.06M
4
RHJA
Rice Hall James & Associates
California
-$5.03M
5
GKIM
GW&K Investment Management
Massachusetts
-$4.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
76
Prudential Financial
New Jersey
$1.85M -$129K -3,971 -7%
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
$1.83M -$115K -3,545 -6%
HF
78
HRT Financial
New York
$1.78M +$1.33M +40,757 +344%
EGI
79
EAM Global Investors
California
$1.74M +$1.67M +51,471 New
Barclays
80
Barclays
United Kingdom
$1.72M +$47.1K +1,449 +3%
Wells Fargo
81
Wells Fargo
California
$1.67M -$124K -3,806 -7%
MAM
82
Martingale Asset Management
Massachusetts
$1.65M +$124K +3,800 +8%
COPPSERS
83
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.65M +$1.59K +49 +0.1%
VOYA Investment Management
84
VOYA Investment Management
Georgia
$1.57M -$157K -4,826 -9%
CS
85
Credit Suisse
Switzerland
$1.53M +$8.17K +251 +0.6%
YCM
86
Yousif Capital Management
Michigan
$1.52M -$21.1K -648 -1%
RA
87
Royce & Associates
New York
$1.51M -$5.08K -156 -0.3%
PP
88
PDT Partners
New York
$1.51M -$693K -21,309 -32%
MUAMU
89
Mitsubishi UFJ Asset Management (UK)
United Kingdom
$1.46M – – –
Assenagon Asset Management
90
Assenagon Asset Management
Luxembourg
$1.43M – – –
Comerica Bank
91
Comerica Bank
Texas
$1.41M -$146K -4,485 -10%
Squarepoint
92
Squarepoint
New York
$1.38M +$1.33M +40,842 New
ISL
93
Ingalls & Snyder LLC
New York
$1.36M – – –
American Century Companies
94
American Century Companies
Missouri
$1.34M +$140K +4,317 +12%
TPSF
95
Texas Permanent School Fund
Texas
$1.3M -$4.23K -130 -0.3%
SOADOR
96
State of Alaska Department of Revenue
Alaska
$1.25M -$108K -3,331 -8%
Fidelity Investments
97
Fidelity Investments
Massachusetts
$1.25M +$16.9K +519 +1%
Citigroup
98
Citigroup
New York
$1.24M +$100K +3,083 +9%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
99
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.23M +$1.18M +36,300 New
Federated Hermes
100
Federated Hermes
Pennsylvania
$1.2M +$1.15M +35,319 +28,483%
2 3
4
5 6

SUPN Hedge Fund Activity: Q3 2022 in Review

244 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q3 2022, worth a combined $1.86B — up 30% from $1.42B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new SUPN positions and 19 closed out — a net gain of 20 holders — while 91 added to existing stakes and 76 trimmed.

The largest buyer was BlackRock, adding an estimated $13.7M. The largest seller was Mesirow Financial Investment Management - Fixed Income, exiting entirely with an estimated $11.5M sold.

  • 244 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q3 2022, up from 225 in Q2 2022.
  • Funds reported $1.86B of Supernus Pharmaceuticals stock for Q3 2022, up 30% quarter-over-quarter.
  • 39 funds opened new Supernus Pharmaceuticals positions in Q3 2022 and 19 closed out, a net change of +20 holders.
  • The largest Supernus Pharmaceuticals buyer in Q3 2022 was BlackRock, an estimated $13.7M added.
  • The largest Supernus Pharmaceuticals seller in Q3 2022 was Mesirow Financial Investment Management - Fixed Income, an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2022.